SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001404644-24-000066
Filing Date
2024-06-17
Accepted
2024-06-17 14:35:11
Documents
13
Period of Report
2024-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20240614.htm   iXBRL 8-K 34426
  Complete submission text file 0001404644-24-000066.txt   161694

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20240614.xsd EX-101.SCH 1907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20240614_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20240614_pre.xml EX-101.PRE 13050
16 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20240614_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 241047788
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)